Q3 EPS Forecast for Privia Health Group Lifted by Analyst

Privia Health Group, Inc. (NASDAQ:PRVA) – Research analysts at Leerink Partnrs upped their Q3 2025 EPS estimates for shares of Privia Health Group in a report released on Tuesday, September 23rd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.09 for the quarter, up from their prior forecast of $0.08. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The business had revenue of $521.15 million for the quarter, compared to analysts’ expectations of $466.97 million. During the same period in the previous year, the business posted $0.19 earnings per share. The company’s revenue for the quarter was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS.

Other research analysts also recently issued reports about the stock. JMP Securities raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Citigroup restated an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. Evercore ISI reduced their target price on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. Piper Sandler reduced their target price on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Finally, Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $28.58.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $23.36 on Wednesday. Privia Health Group has a 1 year low of $16.47 and a 1 year high of $26.09. The company has a market capitalization of $2.87 billion, a P/E ratio of 212.38, a PEG ratio of 3.29 and a beta of 0.82. The company’s fifty day moving average is $21.44 and its two-hundred day moving average is $22.40.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PRVA. CWM LLC raised its position in Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Bessemer Group Inc. raised its position in Privia Health Group by 2,393.4% during the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares during the last quarter. Russell Investments Group Ltd. raised its position in Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after acquiring an additional 2,567 shares during the last quarter. GAMMA Investing LLC raised its position in Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after acquiring an additional 1,521 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its holdings in shares of Privia Health Group by 2,115.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after buying an additional 3,173 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.